Why KinetiSol® Is Disrupting Spray Drying

Dave Miller, Chief Scientific Officer at AustinPx, presents KinetiSol, a technology that promises to reshape the landscape of drug delivery. KinetiSol eliminates the drawbacks of traditional spray dried dispersions (SDDs). Witness real-world examples of how KinetiSol replicates SDDs while removing the need for toxic solvents, streamlining manufacturing and even enhancing the properties of the final drug product.

Dave then contrasts the facility requirements, utilities, and downstream processing needed for SDDs with the simpler approach of KinetiSol.

The latter half of the talk focuses on the undeniable performance benefits of KinetiSol compared to spray drying. Compelling case studies paired with rigorous data showcase how KinetiSol surpasses SDDs in biopharmaceutical performance.

Gain a profound understanding of KinetiSol's capabilities. This commercially-ready process not only replicates SDDs with less complexity and environmental impact but also outperforms spray drying in design and performance.

Learn how to:

• Improve the bioavailability of poorly soluble drugs
• Save time with KinetiSol's fusion-based, solvent-free process
• Leverage the next generation of amorphous dispersion technology